Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. - Wikidata - awgldk - TriplyDB

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

http://www.wikidata.org/entity/Q39186096

about

Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development A neuronal function of the tumor suppressor protein merlin Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation The importance of nerve microenvironment for schwannoma development.Using the neurofibromatosis tumor predisposition syndromes to understand normal nervous system development.In vivo electrophysiological measurements on mouse sciatic nerves The tumor suppressor Nf2 regulates corpus callosum development by inhibiting the transcriptional coactivator Yap.In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.Targeting GTPases in Parkinson's disease: comparison to the historic path of kinase drug discovery and perspectives Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration.Role of Merlin/NF2 inactivation in tumor biology.Role of tau in the spatial organization of axonal microtubules: keeping parallel microtubules evenly distributed despite macromolecular crowding.Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.Towards a functional pathology of hereditary neuropathies.CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins.Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity.The Caenorhabditis elegans NF2/Merlin Molecule NFM-1 Nonautonomously Regulates Neuroblast Migration and Interacts Genetically with the Guidance Cue SLT-1/Slit.Monoclonal antibody Py recognizes neurofilament heavy chain and is a selective marker for large diameter neurons in the brain.Nf2 mutation in Schwann cells delays functional neural recovery following injury.Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2.Update from the 2013 International Neurofibromatosis Conference.[Hereditary tumor syndromes in neuropathology].Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.

P2860

Q24307540-0349E18D-E578-4EB0-9D0D-12150494EAA7 Q26830181-8A6E80AC-9118-49C1-AB98-463947D6BD2C Q27304868-F0D13DF0-A201-428A-9117-AD6A407EB315 Q27321805-5FA11E25-0DD9-44B1-96CB-0499D25D2C19 Q34176631-2D5912A9-FA8B-4C23-87C9-BC297EFECB46 Q34202089-9003E285-E462-4873-821D-94F5DEB91F99 Q34999204-36C76902-1C9D-4FC6-AC5A-1D15EB2CC443 Q35111282-2E21C70D-A730-47D4-A6AB-C858FBCE302E Q35187475-F091A77B-EDE9-4061-9F51-7253D18B96C4 Q36088696-C9CCA59B-4BC4-4308-A5F8-33E867EA68F4 Q36189820-F3A877E4-4300-489D-B0C1-A694F823E5F8 Q37211780-B390AF3C-139E-4286-88E8-325398767FF3 Q37557007-FBC89D47-3281-40BC-83BF-C8B44CF7E922 Q39023144-54F6F75D-6385-4F5B-B845-A8398AD43E24 Q41882383-BA6C8198-6C71-4D32-A888-FE01A62691B1 Q42323518-B4FC118C-D876-41A2-8780-642DD2428CC0 Q48182436-008FC47A-A010-458F-9AF2-0205F7777412 Q48672065-121B296E-75C7-4682-AFA9-D452B22467BD Q50165224-74938A81-93E8-493F-AEE1-E0428927B883 Q53065702-C7391401-B460-4E5A-B745-10452A526AEA Q53083642-6F192668-F26E-4A92-BAF5-2662984AE3AB Q53312284-B477849D-D80C-4D7B-A058-1A1CC458C09E Q55234046-B19C1AEC-DB45-4C00-BCF7-16CAD5C7CD3C Q55638662-A1C7B697-8957-4A51-8E77-5AAC8222E496

P2860

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

http://www.wikidata.org/entity/Q39186096

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

@en

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

@nl

type

label

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

@en

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

@nl

prefLabel

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

@en

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

@nl

P1433

Q39186096-C539A723-AAF1-4AF3-9D30-27B3DC7EBB09

P1476

Q39186096-B5EF9C01-2D1D-4E1E-95A2-C0BA7D9BF9BD

P2093

Q39186096-12044F77-BCB2-4C77-AAFD-D23CDBDB15B6

Q39186096-287A0356-4C0B-4EB7-BAFC-34EABC6C7F79

Q39186096-30AA5272-2016-411A-B591-E192E17ACEE7

Q39186096-3CB17892-7D68-4897-B93E-586845E6DD54

Q39186096-53B0DFFA-3FF3-4968-A99F-B4A604BB210B

Q39186096-61A7FC17-D8D0-46FE-8D40-C2A9B7E9CD7B

Q39186096-6A8F6B69-7DCC-4124-8D59-3FB1E267D65C

Q39186096-7EB1A54B-7EFC-48F4-BC99-9B0920D8819D

Q39186096-88F429EA-1400-4EC1-A1BA-A18A85EC4663

Q39186096-AD402D3A-FD1F-4EB8-B94E-07A4378130B5

P2860

Q39186096-0285F35A-43F7-4D55-A2A3-C1CBF43268F6

Q39186096-220ECB2A-E4ED-4BB7-B6D4-9B2435C2CBAD

Q39186096-2A2B75FD-09E8-416E-9505-71A9D41F25B7

Q39186096-38669AEB-7914-410E-922D-76D00C5761DB

Q39186096-38E1C87F-E871-4B65-8580-FAF34CD6FE02

Q39186096-39F1809C-5514-48FB-8734-B70B52412925

Q39186096-551CC2F5-C08D-44A0-A53F-EDDCF43563DA

Q39186096-67189984-0B3F-4B18-89EE-466A507884F2

Q39186096-6DD281BB-9430-4181-85AF-75DFF8B7EC4D

Q39186096-75E0C600-8399-4F02-8358-FF7A17C8E80F

P2888

Q39186096-937A9B08-B071-4B09-8294-62B19F71B1AD

P304

Q39186096-ABA997EC-3521-4963-BBD5-A3788C2EC1BD

P31

Q39186096-94CB9C44-AB6F-4C8E-836C-EC3ECDE1F9AA

P356

Q39186096-8B8602EF-5532-4C49-8603-4FFCC328F15F

P407

Q39186096-5E2F6108-84B0-48C9-BA61-7FF9DC2C5B4F

P433

Q39186096-9A162F25-541F-4EFD-B2A7-FD75F648FA7A

P478

Q39186096-27DFAEF6-CAD5-4E73-A7F1-1EDE6BF665A3

P50

Q39186096-2B994696-2B43-442C-88AE-0564A010B35B

Q39186096-2E75BB6F-65C5-437E-BD29-A408A67158DC

Q39186096-78B7F46C-2123-42DE-853E-CEE3926E8D94

Q39186096-A379DB24-0921-48BD-94E1-5CB1738B5128

Q39186096-AB4400AF-FE7B-4783-BE96-5EDF5593D991

P577

Q39186096-806C8BC7-54C2-4DF4-A153-63C7986A374A

P5875

Q39186096-8CC0D8A6-582C-412D-8B65-F59C32445541

P698

Q39186096-E235F3BD-EE46-4906-B32C-6C0BEB722E7E

P356

P1433

Nature Neuroscience

P1476

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy

@en

P2093

Alexander Schulz

http://www.w3.org/2001/XMLSchema#string

Christian Hagel

http://www.w3.org/2001/XMLSchema#string

Cynthia Garcia

http://www.w3.org/2001/XMLSchema#string

David B Parkinson

http://www.w3.org/2001/XMLSchema#string

J Michael Schröder

http://www.w3.org/2001/XMLSchema#string

Joachim Weis

http://www.w3.org/2001/XMLSchema#string

Marco Giovannini

http://www.w3.org/2001/XMLSchema#string

Marie Juliane Jung

http://www.w3.org/2001/XMLSchema#string

Michiko Niwa-Kawakita

http://www.w3.org/2001/XMLSchema#string

Reinhard Bauer

http://www.w3.org/2001/XMLSchema#string

P2860

Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells

The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI.

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

Axonal neuregulin-1 regulates myelin sheath thickness

Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments

Mice with the deleted neurofilament of low molecular weight (Nefl) gene: 2. Effects on motor functions and spatial orientation

Rho GTPases in neuronal morphogenesis

Neurofibromatosis type 2.

A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival.

Domain- and site-specific phosphorylation of bovine NF-L by Rho-associated kinase.

P2888

P304

426-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NN.3348

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Clemens O. Hanemann

David H Gutmann

P577

2013-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235776645

http://www.w3.org/2001/XMLSchema#string

P698

23455610

http://www.w3.org/2001/XMLSchema#string